Conference Coverage

Osteoprotegerin ups risk of vascular events in type 1 diabetes

Publish date: July 22, 2013

 

AT THE ANNUAL ADA SCIENTIFIC SESSIONS

pwendling@frontlinemedcom.com

Pages

Recommended Reading

Empagliflozin improves cardiovascular risk factors in T2DM
MDedge Cardiology
Twice daily regimen eases aspirin resistance in diabetes
MDedge Cardiology
Orbital atherectomy shown safe, effective in coronaries
MDedge Cardiology
FDA warns about serious GI symptoms with olmesartan
MDedge Cardiology
Low vitamin D effects on CHD risk vary by race
MDedge Cardiology
Tight inflammation control could reduce CV risk in men with gout
MDedge Cardiology
Roche halts studies of experimental type 2 diabetes drug
MDedge Cardiology
Excessive visceral fat linked to increased risk of CVD, cancer
MDedge Cardiology
Longer duration of obesity linked to coronary calcification
MDedge Cardiology
Vascular testing appropriate use criteria cover 116 scenarios
MDedge Cardiology